comparemela.com

Latest Breaking News On - Intodeworld inc - Page 1 : comparemela.com

iNtRON is finalizing the SAL200 Tech Transfer

/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that the Tech Transfer process of SAL200, endolysin-based new.

United statesSoult ukpyolsiSouth koreaKyonggi doSang hyeonGyeonggi doRepublic of koreaNtron biotechnology incIntodeworld incBd teamTae kyu tk bd team leaderTech transferKyung wonVice presidentTae kyuIntron biotechnology

iNtRON developed advanced bacteriophage engineering platform technology based on modified random mutagenesis

/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that the Company has established the 2nd generation technology of.

United statesSoult ukpyolsiSouth koreaKyonggi doGyeonggi doRepublic of koreaJee sooNtron biotechnology incIntodeworld incBd teamTae kyu tk bd team leaderRobot bacteriophageMcas systemHigh throughput screeningKyung wonVice president

iNtRON completes the sponsorship transfer process for the US Phase 2 study of SAL200

iNtRON completes the sponsorship transfer process for the US Phase 2 study of SAL200

United statesSoult ukpyolsiSouth koreaKyonggi doGyeonggi doRepublic of koreaNtron biotechnology incIntodeworld incBd teamTae kyu tk bd team leaderUs centerKyung wonAntimicrobial resistanceDisease controlBig pharmaVice president

iNtRON developed New CRISPR/Cas technology specific for Bacteriophage as PHAGERUS® Platform

/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) announced today that iNtRON has developed its unique CRISPR/Cas system customized for the.

United statesSoult ukpyolsiSouth koreaKyonggi doGyeonggi doRepublic of koreaJee sooNtron biotechnology incIntodeworld incBd teamTae kyu tk bd team leaderBio drug businessKyung wonVice presidentTae kyuIntron biotechnology

iNtRON Confirms Efficacy of CDL200 Against CDI Clinical Isolates

/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) announced today that CDL200, a novel biological drug candidate under the development of.

United statesSoult ukpyolsiSouth koreaKyonggi doSang hyeonGyeonggi doRepublic of koreaNtron biotechnology incIntodeworld incBd teamTae kyu tk bd team leaderKyung wonInflammatory bowel diseaseVice presidentTae kyuIntron biotechnology

vimarsana © 2020. All Rights Reserved.